Carboplatin and vinorelbine in advanced non-small-cell lung cancer
- 6 March 1996
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 37 (6) , 610-612
- https://doi.org/10.1007/s002800050436
Abstract
A total of 32 patients with advanced non-small-cell lung cancer were treated with carboplatin (350 mg/m2, day 1) and vinorelbine (days 1 and 8) every 28 days. A response rate of 28% (95% confidence limits 12.5 – 43.7%) was observed. The activity of this combination was demonstrated in an outpatient setting with acceptable toxicity.Keywords
This publication has 0 references indexed in Scilit: